DYSPEPSIA IN PREGNANT WOMEN: INFLUENCE OF METABOLIC FACTORS AND EVALUATION OF SAFE THERAPEUTIC APPROACHES
- Authors
-
-
Egamova S. N.
Tashkent State Medical University, Tashkent, Uzbekistan
Author
-
- Keywords:
- Dyspepsia; pregnancy; body mass index; HbA1c, triglycerides; dimethicone; metabolic disorders.
- Abstract
-
Dyspepsia is one of the most common gastrointestinal complaints encountered during pregnancy, arising from a complex interplay of hormonal, mechanical, and metabolic changes that significantly affect maternal comfort and quality of life. Despite its high prevalence, management remains challenging due to limitations in pharmacological options that are safe for the developing foetus. This study aimed to evaluate the role of sociodemographic characteristics, anthropometric indices, and biochemical parameters in dyspepsia among pregnant women, and to assess the effectiveness of safe therapeutic interventions. A prospective observational study was conducted at the polyclinic of Tashkent State Medical University, including 43 pregnant women presenting with dyspeptic symptoms. Data collected included age, trimester, body mass index (BMI), fasting blood glucose, triglycerides, and glycated hemoglobin (HbA1c). Symptom severity was assessed using a standardized 10-point scoring system before and after 14 days of treatment. The results demonstrated that dyspepsia severity increased with advancing gestational age, particularly in the third trimester.
- References
-
1. Gultom A. Dyspepsia in Early Pregnancy as a Result of Hormonal and Functional Changes: A Case Report. International Journal of Health and Pharmaceutical (IJHP). 2026 Feb 14;6(1):211-4.
1. Çolak B. Gut Health Through Gestation: Managing Gastrointestinal System Diseases During Pregnancy. Managing Maternal Chronic Diseases for a Healthy Pregnancy. 2026 Feb 12:101-18.
2. Oliveira KS, Ruy BT, Correa CF, Lima PM. Safety of prescribed drug use among pregnant women attending antenatal care in Midwestern Brazil: A cross-sectional study. International Journal of Risk & Safety in Medicine. 2026 Mar 4:09246479261432738.
3. Sud R, Pebbili KK, Desai SA, Bhagat S, Rathod R, Mane A, Kotak B. Dyspepsia-The Indian perspective: A cross sectional study on demographics and treatment patterns of Dyspepsia from across India (Power 1.0 study). J Assoc Physicians India. 2023 Apr;71(4):11-2.
4. Sinha SK, Kochhar R, Rao KS, Yadav D, Ray S, Singh AP, Sethy PK, Mahajan R, Reddy DV, Sharma VM, Kumar A. Acid peptic disorder compass: An Indian expert consensus on comprehensive management. World Journal of Gastrointestinal Pharmacology and Therapeutics. 2026 Mar 5;17(1):112615.
5. Padayachee N, Bangalee V, Schellack N. Gastro-oesophageal reflux–an overview. SA Pharmaceutical Journal. 2022 Oct 1;89(5):23-9.
6.Karimov MM, Zufarov PS, Pulatova DB, Musaeva LJ. Functional dyspepsia: current aspects of diagnostics and treatment. Cent Asian J Med. 2021;2021(2):Article 16.
7. Makhmudovna AM. Treatment OF Functional Gastrointestinal Dyspepsia. Galaxy International Interdisciplinary Research Journal.;11(2):112-21.
- Downloads
- Published
- 2026-05-06
- Issue
- Vol. 2 No. 5 (2026)
- Section
- Articles
- License
-
This work is licensed under a Creative Commons Attribution 4.0 International License.
